Panagora Asset Management Inc Intercept Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$12.53 - $21.71 $334,864 - $580,199	26,725 New	26,725 $358,000
Q3 2021 Nov 10, 2021	SELL	$12.99 - $20.47 $110,181 - $173,626	-8,482 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$15.46 - $24.5 $126,169 - $199,944	8,161 Added 2542.37%	8,482 $169,000
Q1 2021 May 12, 2021	BUY	$19.33 - $37.75 $6,204 - $12,117	321 New	321 $7,000
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $127,951 - $163,215	-2,427 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $141,251 - $176,588	2,427	2,427 $142,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.